KRAS and non-small cell lung carcinoma: In a multi-genomic study, using 106 human NSCLC cell lines, Kim and colleagues (23) found that the nuclear transport machinery was selectively required for the survival of KRAS-mutant cells that carry a broad range of phenotypic variation.